Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 8-k filed
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Date of Report (Date of earliest event reported): August 3, 2011
Patriot Scientific Corporation
(Exact name of registrant as specified in its charter)
Delaware
0-22182
84-1070278
(State of other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
Carlsbad Corporate Plaza
6183 Paseo Del Norte, Suite 180
Carlsbad, CA 92011
(Address of Principal Executive Offices)
Registrant’s telephone number, including area code: (760) 547-2700
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
o
Soliciting material pursuant to Rule 14A-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01
Other Events.
On August 3, 2011, Patriot Scientific Corporation (the “Company”) issued a letter to its stockholders and a press release that provided updated information regarding: (i) the Company’s action against Technology Properties Limited, LLC, the Company’s fellow member in Phoenix Digital Solutions, LLC, (ii) the operations of the Company’s wholly owned subsidiary, Patriot Data Solutions Group, Inc., and (iii) certain other Company developments. A copy of the press release is attached hereto as Exhibit 99.1.
Item 9.01
Financial Statements and Exhibits
(d)
Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K:
Exhibit
Number
99.1
Press Release issued August 3, 2011
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Patriot Scientific Corporation
Date: August 5, 2011
By:
/s/ Clifford L. Flowers
Clifford L. Flowers

Chief Financial Officer

http://www.sec.gov/Archives/edgar/data/836564/000101968711002458/ptsc_8k-080311.htm
2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply